Charles River Laboratories   3Q Revenues: $425.7 million (+22%) 3Q Earnings: $38.0 million (flat) YTD Revenues: $1.2 billion (+20%) YTD Earnings: $111.1 million (-6%) Comments: Research Models and Services (RMS) revenues were $120.9 million in the quarter, up 3%. Discovery and Safety Assessment (DSA) revenues were $215.8 million, up 36% driven primarily by the acquisitions of WIL Research and Oncotest, which contributed 35% to DSA revenue growth. Revenue for the Manufacturing segme...